Dive deep into the classification, screening criteria, diagnosis, and staging of pulmonary arterial hypertension through the lens of a patient simulation with Dr. Vallerie McLaughlin, Director of the Pulmonary Hypertension Program at the University of Michigan.
Beyond Pulmonary Hypertension Month: Case-Based Simulation in Increasing Awareness about PAH
Be part of the knowledge.™Register
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?
Beyond Pulmonary Hypertension Month: Case-Based Simulation in Increasing Awareness about PAH
Take Post-TestSkip straight to the post-test if you have already participated in this activity
Media formats available:
0.25 credits
Completing the pre-test is required to access this content.
Completing the pre-survey is required to view this content.
Details
Presenters
Overview
Disclosure of Conflicts of Interest
Conflicts of Interest Disclosure Policy:
It is the policy of AKH Inc. to ensure independence, balance, objectivity, scientific rigor, and integrity in all of its continuing education activities. The author must disclose to the participants any significant relationships with ineligible companies whose products or devices may be mentioned in the activity or with the commercial supporter of this continuing education activity. Identified conflicts of interest are mitigated by AKH prior to accreditation of the activity. AKH planners and reviewers have no relevant financial relationships to disclose.Faculty Disclosures
Dr. McLaughlin has disclosed the following financial relationships:
Consultant: Acceleron, Aerovate, Altavant, Bayer, Caremark, Civi Biopharma, Corvista,
Gossamer Bio, Janssen, Merck, United Therapeutics;
Contracted Research: Acceleron, Janssen, Sonovie, United TherapeuticsAccredited Provider Disclosures
Jody Takemoto Ph.D./M.Ed. US HealthConnect / Instructional Designer: has no financial
relationships to disclose.Dorothy Caputo, MA, BSN, RN, AKH Senior Director of Continuing Education & Compliance: has no financial relationships to disclose.
Bernadette Makar, MSN, APRN-BC, NP-C, Nurse Planner/Reviewer: has no financial relationships to disclose.
Dorothy A. Duffy, RPh - AKH Pharmacy Reviewer: has no financial relationships to disclose.All of the relevant financial relationships listed for these individuals have been mitigated.
Target Audience
The intended audience for these activities includes pulmonologists, cardiologists, primary care physicians, PAs, nurse practitioners, pharmacists, nurses and other healthcare professionals interested in the management of patients with pulmonary arterial hypertension.
Learning Objectives
After participating in this educational activity, participants should be better able to:
- Specify the classification, diagnostic screening criteria, diagnosis, and staging of pulmonary arterial hypertension.
Accreditation and Credit Designation Statements
This activity is provided by AKH Inc., Advancing Knowledge in Healthcare.
In support of improving patient care, AKH Inc., Advancing Knowledge in Healthcare is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.Physicians
AKH Inc., Advancing Knowledge in Healthcare designates this enduring material activity for a maximum of 0.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.PhysicianAssistants
AKH Inc., Advancing Knowledge in Healthcare has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 0.25 AAPA Category 1 CME credit. Approval is valid until September 16, 2023. PAs should only claim credit commensurate with the extent of their participation.
Nurses
Credit being awarded: 0.25 ANCC contact hours.Pharmacists
AKH Inc., Advancing Knowledge in Healthcare designates this continuing education activity for 0.25 contact hours.Nurse Practitioners
AKH Inc., Advancing Knowledge in Healthcare is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 030803. This activity is approved for 0.25 contact hour(s) (which includes 0 hour(s) of pharmacology)
Disclaimer
Disclosure of Unlabeled Use
This educational activity may include discussion of uses of agents that are investigational and/or unapproved by the FDA. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.Disclaimer
This course is designed solely to provide the healthcare professional with information to assist in his/her practice and professional development and is not to be considered a diagnostic tool to replace professional advice or treatment. The course serves as a general guide to the healthcare professional, and therefore, cannot be considered as giving legal, nursing, medical, or other professional advice in specific cases. AKH Inc. specifically disclaim responsibility for any adverse consequences resulting directly or indirectly from information in the course, for undetected error, or through participant’s misunderstanding of the content.Provider(s)/Educational Partner(s)
Commercial Support
Supported by an educational grant from Actelion Pharmaceuticals US, Division of Janssen Pharmaceuticals.
System Requirements
Our site requires a computer, tablet, or mobile device and a connection to the Internet. For best results, a high-speed Internet connection is recommended (DSL/Cable/Fibre). We also recommend using the latest version of your favorite browser to ensure compliance with W3C standards, such as Chrome, Safari, Firefox, or Microsoft Edge.
Publication Dates
Release Date:
Expiration Date:
Presenters
Recommended
Details
Presenters
Recommended
Overview
Dive deep into the classification, screening criteria, diagnosis, and staging of pulmonary arterial hypertension through the lens of a patient simulation with Dr. Vallerie McLaughlin, Director of the Pulmonary Hypertension Program at the University of Michigan.
Disclosure of Conflicts of Interest
Conflicts of Interest Disclosure Policy:
It is the policy of AKH Inc. to ensure independence, balance, objectivity, scientific rigor, and integrity in all of its continuing education activities. The author must disclose to the participants any significant relationships with ineligible companies whose products or devices may be mentioned in the activity or with the commercial supporter of this continuing education activity. Identified conflicts of interest are mitigated by AKH prior to accreditation of the activity. AKH planners and reviewers have no relevant financial relationships to disclose.Faculty Disclosures
Dr. McLaughlin has disclosed the following financial relationships:
Consultant: Acceleron, Aerovate, Altavant, Bayer, Caremark, Civi Biopharma, Corvista,
Gossamer Bio, Janssen, Merck, United Therapeutics;
Contracted Research: Acceleron, Janssen, Sonovie, United TherapeuticsAccredited Provider Disclosures
Jody Takemoto Ph.D./M.Ed. US HealthConnect / Instructional Designer: has no financial
relationships to disclose.Dorothy Caputo, MA, BSN, RN, AKH Senior Director of Continuing Education & Compliance: has no financial relationships to disclose.
Bernadette Makar, MSN, APRN-BC, NP-C, Nurse Planner/Reviewer: has no financial relationships to disclose.
Dorothy A. Duffy, RPh - AKH Pharmacy Reviewer: has no financial relationships to disclose.All of the relevant financial relationships listed for these individuals have been mitigated.
Target Audience
The intended audience for these activities includes pulmonologists, cardiologists, primary care physicians, PAs, nurse practitioners, pharmacists, nurses and other healthcare professionals interested in the management of patients with pulmonary arterial hypertension.
Learning Objectives
After participating in this educational activity, participants should be better able to:
- Specify the classification, diagnostic screening criteria, diagnosis, and staging of pulmonary arterial hypertension.
Accreditation and Credit Designation Statements
This activity is provided by AKH Inc., Advancing Knowledge in Healthcare.In support of improving patient care, AKH Inc., Advancing Knowledge in Healthcare is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.Physicians
AKH Inc., Advancing Knowledge in Healthcare designates this enduring material activity for a maximum of 0.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.PhysicianAssistants
AKH Inc., Advancing Knowledge in Healthcare has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 0.25 AAPA Category 1 CME credit. Approval is valid until September 16, 2023. PAs should only claim credit commensurate with the extent of their participation.
Nurses
Credit being awarded: 0.25 ANCC contact hours.Pharmacists
AKH Inc., Advancing Knowledge in Healthcare designates this continuing education activity for 0.25 contact hours.Nurse Practitioners
AKH Inc., Advancing Knowledge in Healthcare is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 030803. This activity is approved for 0.25 contact hour(s) (which includes 0 hour(s) of pharmacology)
Disclaimer
Disclosure of Unlabeled Use
This educational activity may include discussion of uses of agents that are investigational and/or unapproved by the FDA. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.Disclaimer
This course is designed solely to provide the healthcare professional with information to assist in his/her practice and professional development and is not to be considered a diagnostic tool to replace professional advice or treatment. The course serves as a general guide to the healthcare professional, and therefore, cannot be considered as giving legal, nursing, medical, or other professional advice in specific cases. AKH Inc. specifically disclaim responsibility for any adverse consequences resulting directly or indirectly from information in the course, for undetected error, or through participant’s misunderstanding of the content.Provider(s)/Educational Partner(s)
Commercial Support
Supported by an educational grant from Actelion Pharmaceuticals US, Division of Janssen Pharmaceuticals.
System Requirements
Our site requires a computer, tablet, or mobile device and a connection to the Internet. For best results, a high-speed Internet connection is recommended (DSL/Cable/Fibre). We also recommend using the latest version of your favorite browser to ensure compliance with W3C standards, such as Chrome, Safari, Firefox, or Microsoft Edge.
Publication Dates
Release Date:
Expiration Date:
Presenters